Population-based study of survival for women with serous cancer of the ovary, fallopian tube, peritoneum or undesignated origin - on behalf of the Swedish gynecological cancer group (SweGCG).

Dahm-Kähler, Pernilla; Borgfeldt, Christer; Holmberg, Erik; Staf, Christian; Falconer, Henrik; Bjurberg, Maria; Kjölhede, Preben; Rosenberg, Per; Stålberg, Karin; Högberg, Thomas; Åvall-Lundqvist, Elisabeth

Dahm-Kähler, Pernilla; Borgfeldt, Christer; Holmberg, Erik; Staf, Christian; Falconer, Henrik; Bjurberg, Maria; Kjölhede, Preben; Rosenberg, Per; Stålberg, Karin; Högberg, Thomas; Åvall-Lundqvist, Elisabeth.

Afiliação

Dahm-Kähler P; Department of Obstetrics and Gynecology, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden. Electronic address: pernilla.dahm-kahler@vgregion.se.
Borgfeldt C; Department of Obstetrics and Gynecology, Skane University Hospital, Lund University, Lund, Sweden.
Holmberg E; Regional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden; Institute of Clinical Sciences, Sahlgrenska Academy at University of Gothenburg, Gothenburg, Sweden.
Staf C; Regional Cancer Center Western Sweden, Sahlgrenska University Hospital, Gothenburg, Sweden.
Falconer H; Department of Women's and Children's Health, Division of Obstetrics and Gynecology, Karolinska University Hospital and Karolinska Institutet, Stockholm, Sweden.
Bjurberg M; Department of Clinical Sciences, Skane University Hospital, Lund, Sweden.
Kjölhede P; Department of Obstetrics and Gynecology, Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden.
Rosenberg P; Department of Oncology, University Hospital Linköping, Linköping, Sweden.
Stålberg K; Department of Women's and Children's health Uppsala University, Uppsala, Sweden.
Högberg T; Department of Cancer Epidemiology, Lund University, Lund, Sweden.
Åvall-Lundqvist E; Department of Oncology and Department of Clinical and Experimental Medicine, Linköping University, Linköping, Sweden; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

Gynecol Oncol ; 144(1): 167-173, 2017 Jan.

Article em En | MEDLINE | ID: mdl-27817932

Assuntos

Neoplasias das Tubas Uterinas/mortalidade; Neoplasias Císticas, Mucinosas e Serosas/mortalidade; Neoplasias Primárias Desconhecidas/mortalidade; Neoplasias Ovarianas/mortalidade; Neoplasias Peritoneais/mortalidade; Adolescente; Adulto; Idoso; Idoso de 80 Anos ou mais; Protocolos de Quimioterapia Combinada Antineoplásica/uso terapêutico; Quimioterapia Adjuvante; Procedimentos Cirúrgicos de Citorredução; Neoplasias das Tubas Uterinas/patologia; Neoplasias das Tubas Uterinas/terapia; Feminino; Humanos; Pessoa de Meia-Idade; Gradação de Tumores; Estadiamento de Neoplasias; Neoplasia Residual; Neoplasias Císticas, Mucinosas e Serosas/patologia; Neoplasias Císticas, Mucinosas e Serosas/terapia; Neoplasias Primárias Desconhecidas/patologia; Neoplasias Primárias Desconhecidas/terapia; Neoplasias Ovarianas/patologia; Neoplasias Ovarianas/terapia; Neoplasias Peritoneais/patologia; Neoplasias Peritoneais/terapia; Compostos de Platina/uso terapêutico; Sistema de Registros; Taxa de Sobrevida; Suécia/epidemiologia; Adulto Jovem

Palavras-chave

Cancer origin; Ovarian cancer; Serous cancer; Survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Neoplasias Peritoneais / Neoplasias Primárias Desconhecidas / Neoplasias Císticas, Mucinosas e Serosas / Neoplasias das Tubas Uterinas Tipo de estudo: Prognostic_studies Limite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Middle aged País/Região como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google